Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials.

Autor:	Krum, Henry1 henry.krum@med.monash.edu.au, McMurray, John J. V.2, Horton, Edward3, Gerlock, Teresa4, Holzhauer, Bjoern4, Zuurman, Lineke4, Haffner, Steven M.5, Bethel, M. Angelyn6,7, Holman, Rury R.6, Califf, Robert M.7
Zdroj:	Cardiovascular Therapeutics. Apr2010, Vol. 28 Issue 2, p124-132. 9p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu